# NovaScan

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/novascan

- Industry: Medical Devices & Equipment
- Headquarters: Chicago, US
- Website: www.novascaninc.com
- Total disclosed funding: $8M
- Latest round: Series B (Nov 17, 2021)
- Investors on record: 6

## About

Founded in 2001 and based in Chicago, US, NovaScan, Inc. operates as a clinical-stage oncology company that develops solutions for cancer detection and treatment. In November 2021, NovaScan, Inc. raised USD 8 million in Series B funding led by Builders VC.

The company has developed several technology platforms for cancer detection. The technology developed by the company includes cole relaxation frequency, platform technology, predictive technology, novascan marginScan™ skin device, biopsyscan™ breast biopsy, targeted drug delivery, novascan fastscan™ probe, and electrical mammogram.

## Funding rounds

- Series B, Nov 17, 2021, $8M — Gore Range Capital, Builders VC, Harvard Business School Angels Chicago, Dipalo Ventures, Stateline Angels, BioPacific Partners

## Investors

- Gore Range Capital (https://capitalatlas.ai/funds/gore-range-capital) — Series B
- Builders VC (https://capitalatlas.ai/funds/builders-vc) — Series B
- Harvard Business School Angels Chicago — Series B
- Dipalo Ventures (https://capitalatlas.ai/funds/dipalo-ventures) — Series B
- Stateline Angels — Series B
- BioPacific Partners (https://capitalatlas.ai/funds/biopacific-partners) — Series B